SQUAWK/NEWS
Account
Account
Menu
Live News REGULATION FLASH L impact

MRNA - Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA

MRNA - Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA

MRNA

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.